Sorafenib for the treatment of advanced hepatocellular carcinoma: Effectiveness and impact of adverse effects in daily clinical practice

被引：0
|
作者：
Tortora, R. [1 ]
Lanza, A. Galeota [1 ]
Lampasi, F. [1 ]
De Luca, M. [1 ]
Pacilio, R. [1 ]
Tartaglione, M. T. [1 ]
Mattera, S. [1 ]
Di Costanzo, G. G. [1 ]
机构：
[1] Cardarelli Hosp, Liver Unit, Naples, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2011年 / 43卷
关键词：
D O I：
10.1016/S1590-8658(11)60077-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S89 / S90
页数：2
相关论文
共 50 条
  • [1] SORAFENIB FOR THE TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA: EFFECTIVENESS AND IMPACT OF ADVERSE EFFECTS IN DAILY CLINICAL PRACTICE
    Tortora, R.
    Lanza, A. Galeota
    Lampasi, F.
    De Luca, M.
    Pacilio, R.
    Tartaglione, M. T.
    Di Costanzo, G. G.
    [J]. DIGESTIVE AND LIVER DISEASE, 2011, 43 : S180 - S180
  • [2] Safety and Effectiveness of Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma
    Prasanthan, Ardra Thottarath
    Raju, Dona
    Vinayakumar, Syamaprasad Thachethukunnil
    Jacob, Mary
    Chandran, Anand
    Vijayan, Meenu
    Keechilatu, Pavithran
    [J]. CURRENT CANCER THERAPY REVIEWS, 2022, 18 (02) : 148 - 151
  • [3] APPLICABILITY AND SAFETY OF SORAFENIB FOR THE TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA IN THE CONVENTIONAL CLINICAL PRACTICE
    Elisa Reig, Maria
    Forner, Alejandro
    Rimola, Jordi
    Ayuso, Carmen
    Rodriguez de Lope, Carlos
    Llovet, Josep M.
    Bruix, Jordi
    [J]. HEPATOLOGY, 2008, 48 (04) : 963A - 964A
  • [4] Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
    Sanoff, Hanna K.
    Chang, YunKyung
    Lund, Jennifer L.
    O'Neil, Bert H.
    Dusetzina, Stacie B.
    [J]. ONCOLOGIST, 2016, 21 (09): : 1113 - 1120
  • [5] Safety and effectiveness of sorafenib in patients with hepatocellular carcinoma in clinical practice
    Di Costanzo, Giovan Giuseppe
    Tortora, Raffaella
    Iodice, Luca
    Lanza, Alfonso Galeota
    Lampasi, Filippo
    Tartaglione, Maria Teresa
    Picciotto, Francesco Paolo
    Mattera, Silvana
    De Luca, Massimo
    [J]. DIGESTIVE AND LIVER DISEASE, 2012, 44 (09) : 788 - 792
  • [6] Efficacy and Safety of Sorafenib in Advanced Hepatocellular Carcinoma Under Daily Practice Conditions
    Welker, M. W.
    Lubomierski, N.
    Gog, C.
    Herrmann, E.
    Engels, K.
    Vogl, T. J.
    Bechstein, W. O.
    Zeuzem, S.
    Trojan, J.
    [J]. JOURNAL OF CHEMOTHERAPY, 2010, 22 (03) : 205 - 211
  • [7] Effectiveness of sorafenib in the treatment of hepatocellular carcinoma
    Salamanca, P.
    Magalhaes, H.
    Carneiro, F.
    Marques, D.
    Faustino, C.
    Sousa, N.
    Machado, M.
    Ferreira, P.
    Raimundo, A.
    Fragoso, M.
    Lara Santos, L.
    Pereira, D.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 : 52 - 52
  • [8] Cost-effectiveness of Sorafenib for Treatment of Advanced Hepatocellular Carcinoma in India
    Gupta, Nidhi
    Verma, Rohan K.
    Prinja, Shankar
    Dhiman, Radha K.
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2019, 9 (04) : 468 - 475
  • [9] Sorafenib for the treatment of advanced hepatocellular carcinoma
    Connock, M.
    Round, J.
    Bayliss, S.
    Tubeuf, S.
    Greenheld, W.
    Moore, D.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 17 - 21
  • [10] Adverse events of sorafenib in hepatocellular carcinoma treatment
    Pang, Yongsheng
    Eresen, Aydin
    Zhang, Zigeng
    Hou, Qiaoming
    Wang, Yining
    Yaghmai, Vahid
    Zhang, Zhuoli
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (06): : 2770 - 2782
12345